Published in Brain Pathol on November 05, 2009
Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J Neuroinflammation (2011) 1.05
Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation (2010) 1.05
Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link? Mol Neurobiol (2012) 1.04
Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement (2012) 1.04
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment. PLoS One (2012) 0.86
Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol (2011) 0.86
Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1. Glia (2014) 0.82
Astragalus Polysaccharide Protects Astrocytes from Being Infected by HSV-1 through TLR3/NF-κB Signaling Pathway. Evid Based Complement Alternat Med (2014) 0.81
Modulation of neural stem/progenitor cell proliferation during experimental Herpes Simplex encephalitis is mediated by differential FGF-2 expression in the adult brain. Neurobiol Dis (2013) 0.81
Chronic reactive gliosis following regulatory T cell depletion during acute MCMV encephalitis. Glia (2015) 0.79
Activated CD8+ T lymphocytes inhibit neural stem/progenitor cell proliferation: role of interferon-gamma. PLoS One (2014) 0.78
Chronic progressive deficits in neuron size, density and number in the trigeminal ganglia of mice latently infected with herpes simplex virus. Brain Pathol (2011) 0.78
The case for immunomodulatory approaches in treating HSV encephalitis. Future Virol (2013) 0.78
Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner. Int J Alzheimers Dis (2010) 0.77
Infiltration Pattern of Blood Monocytes into the Central Nervous System during Experimental Herpes Simplex Virus Encephalitis. PLoS One (2015) 0.77
Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency. J Immunol (2016) 0.77
Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases. Neurotherapeutics (2016) 0.76
Interferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory Disease. Clin Med Insights Pathol (2016) 0.76
Moving away from amyloid Beta to move on in Alzheimer research. Front Aging Neurosci (2015) 0.76
Herpesviral infection and Toll-like receptor 2. Protein Cell (2012) 0.76
Diet-induced obesity prolongs neuroinflammation and recruits CCR2(+) monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice. Brain Behav Immun (2016) 0.75
Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection. J Neuroimmunol (2017) 0.75
Place navigation impaired in rats with hippocampal lesions. Nature (1982) 15.79
Recognition memory and the medial temporal lobe: a new perspective. Nat Rev Neurosci (2007) 5.74
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 4.70
Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity (2003) 4.49
Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization. Lab Invest (1984) 3.67
Herpes simplex encephalitis: adolescents and adults. Antiviral Res (2006) 2.41
The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol (2007) 2.37
What does the anatomical organization of the entorhinal cortex tell us? Neural Plast (2008) 2.26
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol (1996) 2.14
Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia (2007) 2.04
Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry (1997) 2.02
Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci (1982) 2.02
The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci (2003) 1.94
Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci U S A (2008) 1.91
Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J Exp Med (1998) 1.85
Cell death in HIV dementia. Cell Death Differ (2005) 1.85
Herpes simplex virus encephalitis: chronic progressive cerebral magnetic resonance imaging abnormalities in patients despite good clinical recovery. Clin Infect Dis (1999) 1.52
Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas. Hippocampus (2008) 1.51
Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol (2008) 1.48
Immune control of herpes simplex virus during latency. Curr Opin Immunol (2004) 1.39
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
An explanation for the localization of herpes simplex encephalitis? Ann Neurol (1979) 1.35
Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol (1998) 1.33
Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J Neurochem (2007) 1.25
Olfactory transmission of neurotropic viruses. J Neurovirol (2005) 1.23
The distribution of herpes simplex type 1 antigen in mouse central nervous system after different routes of inoculation. J Neurol Sci (1983) 1.22
Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile. J Neurol Neurosurg Psychiatry (1994) 1.16
Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes (2007) 1.16
Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol Vis Sci (2008) 1.15
Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci (2000) 1.15
Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol (2009) 1.14
Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci (2002) 1.13
The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J Mol Neurosci (2009) 1.13
Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci Lett (2004) 1.12
CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol (2004) 1.11
Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci (1983) 1.08
Herpes simplex infections of the nervous system. Neurol Clin (2008) 1.05
Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Infect Dis (1994) 1.04
Disrupted spatial memory is a consequence of picornavirus infection. Neurobiol Dis (2006) 1.04
Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus. Exp Neurol (2006) 0.98
Fornix lesions selectively abolish place learning in the rat. Exp Neurol (1975) 0.96
CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage. J Virol (2005) 0.94
Neuropathology of herpes simplex virus encephalitis in a rat seizure model. J Neuropathol Exp Neurol (1993) 0.92
Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. PLoS Pathog (2005) 0.91
Neutrophils protect the retina of the injected eye from infection after anterior chamber inoculation of HSV-1 in BALB/c mice. Invest Ophthalmol Vis Sci (2008) 0.90
Macrophages and microglia in HSV-1 infected mouse brain. J Neuroimmunol (1995) 0.89
HIV-1 Vpr potently induces programmed cell death in the CNS in vivo. DNA Cell Biol (2007) 0.88
Persistent Borna Disease Virus (BDV) infection activates microglia prior to a detectable loss of granule cells in the hippocampus. J Neuroinflammation (2008) 0.88
Experimental murine herpes simplex encephalitis: immunohistochemical detection of virus antigens. Neuropathol Appl Neurobiol (1989) 0.86
Herpes simplex virus encephalitis: cranial magnetic resonance imaging and neuropathology in a mouse model. Neurosci Lett (1998) 0.85
Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo. Microbes Infect (2006) 0.85
Spatial recognition memory deficits without notable CNS pathology in rats following herpes simplex encephalitis. J Neurol Sci (1995) 0.85
The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors. Neuropsychiatry Neuropsychol Behav Neurol (1997) 0.83
Induction of apoptosis by herpes simplex virus-1 in neonatal, but not adult, neutrophils. Pediatr Res (2005) 0.83
Herpes simplex virus encephalitis: chronic progressive cerebral MRI changes despite good clinical recovery and low viral load - an experimental mouse study. Eur J Neurol (1999) 0.82
Placing hippocampal single-unit studies in a historical context. Hippocampus (1999) 0.79
Central Nervous System Infections in the Immune-competent Adult. Curr Treat Options Neurol (2002) 0.77
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A (2010) 3.58
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol (2006) 3.42
Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol (2002) 2.72
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T. Magn Reson Med (2004) 2.25
Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev (2005) 2.07
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev (2009) 1.90
Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol (2005) 1.88
Comparison of analytical mathematical approaches for identifying key nuclear magnetic resonance spectroscopy biomarkers in the diagnosis and assessment of clinical change of diseases. J Comp Neurol (2010) 1.71
Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells Dev (2008) 1.65
Morphine induces apoptosis of human microglia and neurons. Neuropharmacology (2002) 1.61
Stem cells for ischemic brain injury: a critical review. J Comp Neurol (2009) 1.53
Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells (2005) 1.51
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49
De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res (2009) 1.49
Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol (2008) 1.48
Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene. Mol Ther (2004) 1.44
Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem (2007) 1.38
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A (2002) 1.29
Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci U S A (2003) 1.27
Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neurooncol (2006) 1.27
Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia (2004) 1.26
Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol (2007) 1.24
Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis (2005) 1.20
Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab (2002) 1.19
Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res (2006) 1.18
In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. J Immunother (2007) 1.18
Differential responses of human brain cells to West Nile virus infection. J Neurovirol (2005) 1.17
Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis (2005) 1.17
TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J Leukoc Biol (2005) 1.14
Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I. Neurobiol Dis (2011) 1.14
Apoptosis-associated microRNAs are modulated in mouse, rat and human neural differentiation. BMC Genomics (2010) 1.12
Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann N Y Acad Sci (2005) 1.11
High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res (2004) 1.09
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol (2006) 1.08
CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08
Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res (2005) 1.07
Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant (2003) 1.05
Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J Neuroinflammation (2011) 1.05
Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation (2010) 1.05
Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy. Brain Res Bull (2007) 1.04
Apoptosis in transgenic mice expressing the P301L mutated form of human tau. Mol Med (2008) 1.03
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. Trends Mol Med (2008) 1.03
Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes. J Neurovirol (2004) 1.03
Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia (2010) 1.02
Murine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brain. PLoS One (2011) 1.01
Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther (2006) 1.01
ROC-supervised principal component analysis in connection with the diagnosis of diseases. Am J Transl Res (2011) 1.00
Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res (2007) 1.00
Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1. J Neurovirol (2006) 0.99
Detection of neuronal loss using T(1rho) MRI assessment of (1)H(2)O spin dynamics in the aphakia mouse. J Neurosci Methods (2008) 0.98
Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. Cell Transplant (2002) 0.97
Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells. J Neurosci Res (2009) 0.96
Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia. J Neuroinflammation (2007) 0.96
Mathematical prognostic biomarker models for treatment response and survival in epithelial ovarian cancer. Cancer Inform (2011) 0.96
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol (2006) 0.96
Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas. J Neurooncol (2006) 0.96
Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. Am J Chin Med (2007) 0.95
Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. J Neurovirol (2011) 0.95
Application of clustering analyses to the diagnosis of Huntington disease in mice and other diseases with well-defined group boundaries. Comput Methods Programs Biomed (2011) 0.94
Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol (2008) 0.94
Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration. Mol Genet Metab (2012) 0.93
U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol (2003) 0.93
Morphine stimulates CCL2 production by human neurons. J Neuroinflammation (2006) 0.92
Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology (2012) 0.92
T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma. J Neurovirol (2005) 0.91
Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation. J Cell Biochem (2009) 0.90
Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis (2002) 0.90